Drug

Silver-stained kidney micrograph showing two glomeruli with thickened basement membranes, the pattern seen in membranous nephropathy

November 14, 2026

FDA Approves Gazyva (Obinutuzumab) for Primary Membranous Nephropathy as First Dedicated Treatment

If you have primary membranous nephropathy, your condition had no FDA-approved treatment made for it. Doctors used drugs cleared for other diseases, without PMN-specific trial data. That changed on November 13, 2026,

Extreme close-up of a human eye showing the iris and pupil, illustrating vision and eye health

Health·Latest·Policy·USA

FDA orders NAION vision-loss warning on all 12 GLP-1 drugs including Ozempic, Mounjaro, and Foundayo

If you take Ozempic, Wegovy, Mounjaro, Zepbound, or any other GLP-1 medication, a new federal warning about sudden vision loss may sound alarming. Here’s what the FDA actually found, and what it means for your prescription. On November 9, 2026,

November 12, 2026

Thyroid Medication Recall: Potentially Superpotent Vitruvias Tablets Need a Lot Check

Health

What Is Being Recalled A nationwide recall has been reported for one lot of Thyroid Tablets USP 30 mg, a porcine-derived thyroid medication containing

Compounded Injectable Safety Alerts Cite Sterility Concerns for Semaglutide, Tirzepatide, and Sermorelin

Health·News

Patients who have received compounded injectable medications — specifically semaglutide, tirzepatide, or sermorelin — from a pharmacy connected to recent safety alerts should contact

The Lyceum building at the University of Mississippi in Oxford.

Health·News

Ole Miss student deaths: father and son face federal charges

Parents and students at the University of Mississippi have heard fast-moving reports about two student deaths. A federal case now links drug charges to the investigation of one of those deaths. A

Tejal Somvanshi

October 11, 2026

Hayden Panettiere smiling at Fan Expo Toronto in 2011, cropped from a licensed event photograph.

Health·News

Hayden Panettiere Cause Of Death Still Unconfirmed At 36 As Federal Drug Inquiry Expands

If you have seen headlines claiming fentanyl killed Hayden Panettiere, here is the important clarification: as of September 14, 2026, her official cause and manner of death have not been announced. Investigators

Sunita Somvanshi

September 15, 2026

Health

Acetaminophen in Pregnancy Study Finds Smaller Ovarian and Uterine Measures in Girls

A new study links prenatal acetaminophen to reproductive changes in girls, with researchers finding 40% smaller ovarian volume, 13% smaller uterine volume, and 23% fewer ovarian follicles among girls exposed in the

Tejal Somvanshi

September 10, 2026

Close-up photograph of assorted pharmaceutical blister strips and medicinal tablets on a clean surface.

Health·India·News

UP Fake Medicine Ring Busted: WHO Warns 1 in 10 Drugs in Developing Nations Fail Safety Checks

In early September 2026, a coordinated raid by Uttar Pradesh’s Food Safety and Drug Administration and state police raided premises suspected of operating a counterfeit pharmaceutical network running between Saharanpur and Lucknow.

Tejal Somvanshi

September 3, 2026

Medicines displayed on a shelf, used for paracetamol double-dosing safety coverage

Health·News·UK

Young Adults Swap Alcohol for Prescription Drugs, Dividing Experts

A growing number of young adults in the UK are reported to be taking prescription drugs instead of alcohol in social settings, a trend that has divided medical and public health experts

Tejal Somvanshi

August 18, 2026

A healthcare worker administers an injection, representing clinical research into one-time cholesterol-lowering gene-editing treatment.

Health·Science

Twice-Yearly Inclisiran Injection Shows Major LDL Reduction, Offering New Hope for Heart Patients

New clinical trial data published in July 2026 shows that inclisiran, a twice-yearly injectable cholesterol treatment, produces major reductions in low-density lipoprotein (LDL) cholesterol — the primary cardiovascular risk marker commonly called

Tejal Somvanshi

July 30, 2026

Health·Policy·Politics·USA

Trump Administration Ends Medicare Part D Subsidies, Raising Drug Costs for Seniors

The Trump administration announced it will end the low-income subsidy structure within Medicare Part D prescription drug plans, a move that health policy analysts say will increase out-of-pocket costs for millions of

Govind Tekale

July 30, 2026

Capitol setting reflecting shifting healthcare policy and legislative debate

Health·Policy·USA

“Nothing More Than a Glorified Coupon Book” — What Congress Found After Checking TrumpRx’s 43 Drug Price Claims

TrumpRx Drug Price Reality Check Health Policy · Feb 2026 TrumpRx DrugPrice RealityCheck The White House says TrumpRx.gov offers the world’s lowest prescription drug prices. Congressional investigators say nearly half the claims

Tejal Somvanshi

February 25, 2026

Health·News

LifeMD’s NovoCare Offers $499 Wegovy—Telehealth GLP-1 Scripts Jump 10% as U.S. Obesity Tops 40%

LifeMD is linking arms with NovoCare Pharmacy to offer Wegovy (semaglutide) at $499 monthly for cash-pay patients through its virtual care platform. This move comes as several telehealth companies race to simplify

Sunita Somvanshi

April 30, 2025

Health·News

Pfizer Oral GLP-1 Danuglipron Dropped After 73% Nausea and One Liver Injury Case Among 1,400 Patients

Pfizer has pulled the plug on danuglipron (PF-06882961), its experimental once-daily oral GLP-1 receptor agonist for weight management, after a participant in an early-stage dose-optimization trial developed potential drug-induced liver injury (DILI).

Tejal Somvanshi

April 17, 2025

1 2 3 Next